237 related articles for article (PubMed ID: 22996848)
1. A predictive model for intrathecal opioid dose escalation for chronic non-cancer pain.
Duarte RV; Raphael JH; Haque MS; Southall JL; Ashford RL
Pain Physician; 2012; 15(5):363-9. PubMed ID: 22996848
[TBL] [Abstract][Full Text] [Related]
2. Outcome of intrathecal opioids in chronic non-cancer pain.
Roberts LJ; Finch PM; Goucke CR; Price LM
Eur J Pain; 2001; 5(4):353-61. PubMed ID: 11743701
[TBL] [Abstract][Full Text] [Related]
3. Intrathecal opioid therapy for chronic nonmalignant pain: a retrospective cohort study with 3-year follow-up.
Atli A; Theodore BR; Turk DC; Loeser JD
Pain Med; 2010 Jul; 11(7):1010-6. PubMed ID: 20492572
[TBL] [Abstract][Full Text] [Related]
4. Age-dependent intrathecal opioid escalation in chronic noncancer pain patients.
Hayek SM; Veizi IE; Narouze SN; Mekhail N
Pain Med; 2011 Aug; 12(8):1179-89. PubMed ID: 21810164
[TBL] [Abstract][Full Text] [Related]
5. Factors that might impact intrathecal drug delivery (IDD) dose escalation: a longitudinal study.
Mekhail N; Mahboobi R; Farajzadeh Deroee A; Costandi S; Dalton J; Guirguis M; Mehta P
Pain Pract; 2014 Apr; 14(4):301-8. PubMed ID: 23803173
[TBL] [Abstract][Full Text] [Related]
6. Patient selection and outcomes using a low-dose intrathecal opioid trialing method for chronic nonmalignant pain.
Grider JS; Harned ME; Etscheidt MA
Pain Physician; 2011; 14(4):343-51. PubMed ID: 21785477
[TBL] [Abstract][Full Text] [Related]
7. Combination of intrathecal opioids with bupivacaine attenuates opioid dose escalation in chronic noncancer pain patients.
Veizi IE; Hayek SM; Narouze S; Pope JE; Mekhail N
Pain Med; 2011 Oct; 12(10):1481-9. PubMed ID: 21943351
[TBL] [Abstract][Full Text] [Related]
8. Continuous intrathecal morphine infusion in patients with vertebral fractures due to osteoporosis.
Shaladi A; Saltari MR; Piva B; Crestani F; Tartari S; Pinato P; Micheletto G; Dall'Ara R
Clin J Pain; 2007; 23(6):511-7. PubMed ID: 17575491
[TBL] [Abstract][Full Text] [Related]
9. Intrathecal treatment in cancer patients unresponsive to multiple trials of systemic opioids.
Mercadante S; Intravaia G; Villari P; Ferrera P; Riina S; David F; Mangione S
Clin J Pain; 2007; 23(9):793-8. PubMed ID: 18075407
[TBL] [Abstract][Full Text] [Related]
10. Drug-related side effects of long-term intrathecal morphine therapy.
Ruan X
Pain Physician; 2007 Mar; 10(2):357-66. PubMed ID: 17387357
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and influence of diagnostic criteria in the assessment of hypogonadism in intrathecal opioid therapy patients.
Duarte RV; Raphael JH; Labib M; Southall JL; Ashford RL
Pain Physician; 2013 Jan; 16(1):9-14. PubMed ID: 23340538
[TBL] [Abstract][Full Text] [Related]
12. Prospective study of 3-year follow-up of low-dose intrathecal opioids in the management of chronic nonmalignant pain.
Hamza M; Doleys D; Wells M; Weisbein J; Hoff J; Martin M; Soteropoulos C; Barreto J; Deschner S; Ketchum J
Pain Med; 2012 Oct; 13(10):1304-13. PubMed ID: 22845187
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous treatment of intractable pain and spasticity: observations of combined intrathecal baclofen-morphine therapy over a 10-year clinical experience.
Saulino M
Eur J Phys Rehabil Med; 2012 Mar; 48(1):39-45. PubMed ID: 21525824
[TBL] [Abstract][Full Text] [Related]
14. Conversion of chronic pain patients from full-opioid agonists to sublingual buprenorphine.
Daitch J; Frey ME; Silver D; Mitnick C; Daitch D; Pergolizzi J
Pain Physician; 2012 Jul; 15(3 Suppl):ES59-66. PubMed ID: 22786462
[TBL] [Abstract][Full Text] [Related]
15. Preliminary study of the plasma and cerebrospinal fluid concentrations of IL-6 and IL-10 in patients with chronic pain receiving intrathecal opioid infusions by chronically implanted pump for pain management.
Zin CS; Nissen LM; O'Callaghan JP; Moore BJ; Smith MT
Pain Med; 2010 Apr; 11(4):550-61. PubMed ID: 20202139
[TBL] [Abstract][Full Text] [Related]
16. Intrathecal atipamezole augments the antinociceptive effect of morphine in rats.
Lilius TO; Rauhala PV; Kambur O; Rossi SM; Väänänen AJ; Kalso EA
Anesth Analg; 2012 Jun; 114(6):1353-8. PubMed ID: 22556211
[TBL] [Abstract][Full Text] [Related]
17. [Management of pain from osteoporotic vertebral fractures with continuous intrathecal administration of morphine].
Piva B; Shaladi A; Crestani F; Saltari R; Micheletto G; Pinato G
Recenti Prog Med; 2007 Apr; 98(4):225-31. PubMed ID: 17547359
[TBL] [Abstract][Full Text] [Related]
18. Long-term use of intrathecal droperidol as an excellent antiemetic in nonmalignant pain--a retrospective study.
Ahmad-Sabry MH; Shareghi G
Middle East J Anaesthesiol; 2012 Oct; 21(6):857-62. PubMed ID: 23634568
[TBL] [Abstract][Full Text] [Related]
19. Factors predicting requirement of high-dose transdermal fentanyl in opioid switching from oral morphine or oxycodone in patients with cancer pain.
Kanbayashi Y; Hosokawa T; Okamoto K; Fujimoto S; Konishi H; Otsuji E; Yoshikawa T; Takagi T; Miki T; Taniwaki M
Clin J Pain; 2011 Oct; 27(8):664-7. PubMed ID: 21471811
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzodiazepine and/or antidepressant therapy in chronic non-cancer pain.
Manchikanti L; Manchikanti KN; Pampati V; Cash KA
Pain Physician; 2009; 12(1):259-67. PubMed ID: 19165308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
